Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Winglore
Ipilimumab 50mg/10mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Winglore
Ipilimumab 200mg/40mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Yervoy
Ipilimumab 50mg/10mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Yervoy
Ipilimumab 200mg/40mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
|
Dated this 25th day of September 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz